A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation

Charlson, 1984, Applying results of randomised trials to clinical practice: Impact of losses before randomization, Br Med J, 289, 1281, 10.1136/bmj.289.6454.1281 Sackett, 1979, Controversy in counting and attributing events in clinical trials, N Engl J Med, 301, 1410, 10.1056/NEJM197912273012602 Feinstein, 1970, The pre-therapeutic classification of co-morbidity in chronic disease, J Chron Dis, 23, 455, 10.1016/0021-9681(70)90054-8 Kaplan, 1974, The importance of classifying initial comorbidity in evaluating the outcome of diabetes mellitus, J Chron Dis, 27, 387, 10.1016/0021-9681(74)90017-4 Charlson, 1986, Assessing illness severity: Does clinical judgment work?, J Chron Dis, 39, 439, 10.1016/0021-9681(86)90111-6 Charlson, 1984, Rate of disease progression in breast cancer: A clinical estimate of growth rate within nodal and anatomic stages, J Natl Cancer Inst, 72, 225 Cutler, 1958, Maximum utilization of the life table method in analyzing survival, J Chron Dis, 8, 699, 10.1016/0021-9681(58)90126-7 Peto, 1977, Design and analysis of randomized trials requiring prolonged observation of each patient, Br J Cancer, 35, 1, 10.1038/bjc.1977.1 Cox, 1972, Regression models and life tables, J R Stat Soc, 34, 187 Harrell, 1980, The PHGLM procedure, 119 Lee, 1980, Identification of prognostic factors related to survival time, 298 Hutchinson, 1982, Predicting survival in adults with end stage renal disease—an age equivalence index, Ann Int Med, 96, 417, 10.7326/0003-4819-96-4-417 Prentice, 1978, The analysis of failure times in the presence of competing risks, Biometrics, 34, 541, 10.2307/2530374